Saturday, July 11, 2026

pharma · Infertility · Ovarian Cancer · NWBO

NORTHWEST BIOTHERAPEUTICS

NORTHWEST BIOTHERAPEUTICS is a pharma organization headquartered in Bethesda, USA. It trades on NYSE under ticker NWBO. Primary therapeutic focus areas include Infertility, Ovarian Cancer, Environmental Exposure, Colorec

4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US HQ
1998 Founded
20 Employees
Public company Type
NWBO · NYSE Ticker
Company details
Status
Public
HQ
4800 Montgomery Lane, Suite 800, Bethesda, MD 28014, US
Founded
1998
Employees
20
Programs
33
Drugs
40
Patents
595
Clinical program

Menopur 150 international units

Phase 1 · small molecule · Pregnancy

Menopur 150 international units for Pregnancy is a Phase 1 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

← All NORTHWEST BIOTHERAPEUTICS INC projects Phase 1 small molecule terminated

Internal code IVFFL001v2

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
NORTHWEST BIOTHERAPEUTICS INC
Phase
Phase 1
Modality
small_molecule
Indication
Pregnancy
Status
terminated
Trials
1